ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPGN OpGen Inc

0.515
-0.017 (-3.20%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
OpGen Inc NASDAQ:OPGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.017 -3.20% 0.515 0.50 0.515 0.552 0.48 0.54 437,254 22:22:49

OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call

05/03/2018 9:00pm

GlobeNewswire Inc.


OpGen (NASDAQ:OPGN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more OpGen Charts.

OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday, March 15, 2018. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.

Dial-in InformationU.S. Dial-In Number: (888) 883-4599International Dial-In Number: (484) 653-6821Conference ID: 8899787

Replay Dial-in InformationU.S. Dial-In Number: (855) 859-2056   International Dial-In Number: (404) 537-3406Conference ID: 8899787

Following the conclusion of the conference call, a replay will be available through March 22, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at http://ir.opgen.com. A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.

About OpGenOpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection treatment and prevention. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.

OpGen, Acuitas, and Acuitas Lighthouse are registered trademarks of OpGen, Inc.  All other trademarks are properties of their respective owners.

OpGen Contact:Michael FarmerSr. Director, Marketing240-813-1284mfarmer@opgen.comInvestorRelations@opgen.com

Investor Contacts:LHA Investor RelationsKim Sutton Golodetz212-838-3777kgolodetz@lhai.comorBruce Voss310-691-7100bvoss@lhai.com

1 Year OpGen Chart

1 Year OpGen Chart

1 Month OpGen Chart

1 Month OpGen Chart

Your Recent History

Delayed Upgrade Clock